Skip to Content Skip to Navigation

Practical matters How to find us drs. A.T. (Tim) Otten

University Medical Center Groningen

drs. A.T. (Tim) Otten

No picture available

Faculty of Medical Sciences

Telephone:

E-mail:

a.t.otten umcg.nl

ORCID Research Portal

Publications

Assessment of Fecal Glycosylated Mucins as Novel Biomarkers in Inflammatory Bowel Diseases

Geertsema, S. , Otten, A. T. , Bouwknegt, D. G. , Visschedijk, M. C. & Bourgonje, A. R. , 10-Jan-2023 , (E-pub ahead of print) In: Inflammatory Bowel Diseases. 2 p. , izac265.

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

The Risk of Developing Long COVID in Patients with Inflammatory Bowel Diseases: Do Immunosuppressive Drugs Matter?

Bourgonje, A. R. & Otten, A. T. , 13-Jan-2023 , (Accepted/In press) In: Clinical Gastroenterology and Hepatology. 4 p.

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

Working towards a comprehensive appraisal of vaccine-induced immunity against SARS-CoV-2 in IBD

Otten, A. T. , Bourgonje, A. R. & Visschedijk, M. C. , Feb-2023 , In: The Lancet Gastroenterology and Hepatology. 8 , 2 , p. 99-100 2 p.

Research output: Contribution to journal › Editorial › Academic › peer-review

Serological biomarkers of type I, III, and IV collagen turnover are associated with the presence and future progression of stricturing and penetrating Crohn's disease

Bourgonje, A. R. , Alexdóttir, M. S. , Otten, A. T. , Loveikyte, R. , Bay-Jensen, A-C. , Pehrsson, M. , van Dullemen, H. M. , Visschedijk, M. C. , Festen, E. A. M. , Weersma, R. K. , Karsdal, M. A. , Faber, K. N. , Mortensen, J. H. & Dijkstra, G. , Aug-2022 , In: Alimentary Pharmacology & Therapeutics. 56 , 4 , p. 675-693 19 p.

Research output: Contribution to journal › Article › Academic › peer-review

The effect of riboflavin supplementation on the systemic redox status in healthy volunteers: A post-hoc analysis of the RIBOGUT trial

Bourgonje, A. R. , Otten, A. T. , Sadaghian Sadabad, M. , von Martels, J. Z. H. , Bulthuis, M. L. C. , Faber, K. N. , van Goor, H. , Dijkstra, G. & Harmsen, H. J. M. , Sept-2022 , In: Free Radical Biology and Medicine. 190 , p. 169-178 10 p.

Research output: Contribution to journal › Article › Academic › peer-review

Use of Tumor Necrosis Factor-α Antagonists is Associated with Attenuated IgG Antibody Response against SARS-CoV-2 in Vaccinated Patients with Inflammatory Bowel Disease

Otten, A. T. , Bourgonje, A. R. , Horinga, P. P. , van der Meulen, H. H. , Festen, E. A. M. , van Dullemen, H. M. , Weersma, R. K. , van Leer-Buter, C. C. , Dijkstra, G. & Visschedijk, M. C. , 5-Jul-2022 , In: Frontiers in Immunology. 13 , p. 1-12 12 p. , 920333.

Research output: Contribution to journal › Article › Academic › peer-review

Infliximab formulation strategy for a stable ileo-colonic targeted oral dosage form intended for the topical treatment of inflammatory bowel disease

Gareb, B. , Beugeling, M. , Posthumus, S. , Otten, A. T. , Dijkstra, G. , Kosterink, J. G. W. & Frijlink, H. W. , Aug-2021 , In: Journal of drug delivery science and technology. 64 , 10 p. , 102552.

Research output: Contribution to journal › Article › Academic › peer-review

Use of TNF-α-antagonists and systemic steroids is associated with attenuated imunogenicity against SARS-CoV-2 in fully vaccinated patients with Inflammatory Bowel Disease

Otten, A. T. , Bourgonje, A. R. , Horinga, P. P. , van der Meulen, H. H. , van Leer-Buter, C. C. , Dijkstra, G. & Visschedijk, M. C. , 22-Jan-2021 , In: Journal of Crohn's and Colitis. 16 , Suppl(1) , p. S538 1 p.

Research output: Contribution to journal › Meeting Abstract › Academic

Vitamin C Supplementation in Healthy Individuals Leads to Shifts of Bacterial Populations in the Gut - A Pilot Study

Otten, A. T. , Bourgonje, A. R. , Peters, V. , Alizadeh, B. Z. , Dijkstra, G. & Harmsen, H. J. , 12-Aug-2021 , In: Antioxidants. 10 , 8 , 13 p. , 1278.

Research output: Contribution to journal › Article › Academic › peer-review

Review: Local Tumor Necrosis Factor-alpha Inhibition in Inflammatory Bowel Disease

Gareb, B. , Otten, A. T. , Frijlink, H. W. , Dijkstra, G. & Kosterink, J. G. W. , 11-Jun-2020 , In: Pharmaceutics. 12 , 6 , p. 1-31 34 p. , 539.

Research output: Contribution to journal › Review article › peer-review

All (11) publications

View full research profile

Follow the UGfacebook twitter linkedin rss instagram youtube